Dexmedetomidine premix formulation

摘要

The presently disclosed subject matter relates to pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof wherein the composition is formulated as a liquid for parenteral administration to a subject, and wherein the composition is disposed within a sealed container as a premixture. The pharmaceutical compositions can be used, for example, in perioperative care of a patient or for sedation.

主权项

1. A ready to use liquid pharmaceutical composition for parenteral administration to a subject, comprising dexmedetomidine at a concentration of about 0.005 to about 50 ug/mL disposed within a sealed glass container, wherein the dexmedetomidine is formulated as a hydrochloride salt.